Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Arnold

Showing results (851-860 of 881) with videos related to

Pageof 89
Sort By:
Journal of Sleep Research|July 9, 2025
Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised Controlled TrialAnastasia Suraev, Iain S McGregor, Danielle McCartney, et al.
Nature|December 12, 2022
Active eosinophils regulate host defence and immune responses in colitisAlessandra Gurtner, Costanza Borrelli, Ignacio Gonzalez-Perez, et al.
Science Immunology|August 8, 2025
GM-CSF derived from alveolar type 2 cells promotes CD301b<sup>+</sup> cDC2 generation and allergic airway inflammationJulia Gschwend, Antonie Lechner, Nikolaos D Sidiropoulos, et al.
Developmental Cell|November 27, 2024
Adeno-associated viral tools to trace neural development and connectivity across amphibiansEliza C B Jaeger, David Vijatovic, Astrid Deryckere, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 22, 2023
CTP-based estimated ischemic core: A comparative multicenter study between Olea and RAPID softwareV Yedavalli, S Kihira, P Shahrouki, et al.
Addiction Science & Clinical Practice|July 26, 2024
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorderChristopher S Freet, Brianna Evans, Timothy R Brick, et al.
Clinical Toxicology (Philadelphia, Pa.)|November 1, 2014
Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trialSean P Bush, Anne-Michelle Ruha, Steven A Seifert, et al.
The Pediatric Infectious Disease Journal|February 25, 2025
Plasma Microbial Cell-free DNA Sequencing for the Detection of Kingella kingae Pediatric Spinal InfectionsAsim A Ahmed, Sarah Y Park, Matthew J Smollin, et al.
Cancers|February 10, 2024
Novel LIPA-Targeted Therapy for Treating Ovarian CancerAlexia B Collier, Suryavathi Viswanadhapalli, Rahul Gopalam, et al.
BMC Infectious Diseases|January 6, 2016
Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenzaJohn H Powers, M Lourdes Guerrero, Nancy Kline Leidy, et al.
Pageof 89

Showing results (851-860 of 881) with videos related to

Sort By:
Pageof 89
Journal of Sleep Research|July 9, 2025
Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised Controlled TrialAnastasia Suraev, Iain S McGregor, Danielle McCartney, et al.
Nature|December 12, 2022
Active eosinophils regulate host defence and immune responses in colitisAlessandra Gurtner, Costanza Borrelli, Ignacio Gonzalez-Perez, et al.
Science Immunology|August 8, 2025
GM-CSF derived from alveolar type 2 cells promotes CD301b<sup>+</sup> cDC2 generation and allergic airway inflammationJulia Gschwend, Antonie Lechner, Nikolaos D Sidiropoulos, et al.
Developmental Cell|November 27, 2024
Adeno-associated viral tools to trace neural development and connectivity across amphibiansEliza C B Jaeger, David Vijatovic, Astrid Deryckere, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 22, 2023
CTP-based estimated ischemic core: A comparative multicenter study between Olea and RAPID softwareV Yedavalli, S Kihira, P Shahrouki, et al.
Addiction Science & Clinical Practice|July 26, 2024
Ecological momentary assessment and cue-elicited drug craving as primary endpoints: study protocol for a randomized, double-blind, placebo-controlled clinical trial testing the efficacy of a GLP-1 receptor agonist in opioid use disorderChristopher S Freet, Brianna Evans, Timothy R Brick, et al.
Clinical Toxicology (Philadelphia, Pa.)|November 1, 2014
Comparison of F(ab')2 versus Fab antivenom for pit viper envenomation: a prospective, blinded, multicenter, randomized clinical trialSean P Bush, Anne-Michelle Ruha, Steven A Seifert, et al.
The Pediatric Infectious Disease Journal|February 25, 2025
Plasma Microbial Cell-free DNA Sequencing for the Detection of Kingella kingae Pediatric Spinal InfectionsAsim A Ahmed, Sarah Y Park, Matthew J Smollin, et al.
Cancers|February 10, 2024
Novel LIPA-Targeted Therapy for Treating Ovarian CancerAlexia B Collier, Suryavathi Viswanadhapalli, Rahul Gopalam, et al.
BMC Infectious Diseases|January 6, 2016
Development of the Flu-PRO: a patient-reported outcome (PRO) instrument to evaluate symptoms of influenzaJohn H Powers, M Lourdes Guerrero, Nancy Kline Leidy, et al.
Pageof 89